On September 17, NACDS and representatives from NACDS member pharmacies participated in a meeting with the White House Office of Pandemic Preparedness and Response Policy to discuss pharmacy needs for the current respiratory season as well as future, potential response efforts. Pictured here left to right on the front row are Sara Roszak, NACDS’ senior vice president of health and wellness strategy and policy; Anita Patel, vice president of pharmacy services development, Walgreen Co.; and Doug Cornelius, director of pharmacy operations, Kroger Health. Pictured in the back row left to right are Lisa Smith, senior director II, clinical operations and strategy, Walmart Health and Wellness; Summer Kerley, group vice president of pharmacy growth and operations, Rite Aid Corporation; past NACDS Chair Mike Wysong, chief executive officer of CARE Pharmacies; Charley John, senior director of healthcare policy and strategy, Walgreen Co.; NACDS President and CEO Steven C. Anderson; and Nimesh Jhaveri, executive vice president and chief impact officer, McKesson Corporation.

Share this story:

Related Posts

  • New Employer Playbook Positions Pharmacies as a Powerful Lever Against Rising Healthcare Costs

    Guide gives HR and benefits leaders a step-by-step roadmap to expand employee access to care and lower costs through local pharmacies.

  • NACDS to Senate Armed Services Subcommittee: Strengthen the TRICARE Pharmacy Program Through Access, Choice, Transparency, and Accountability

    NACDS urges Congress to preserve TRICARE pharmacy oversight provisions in the Fiscal Year 2027 NDAA.

  • ICYMI: Dr. Oz Highlights Pharmacists’ Role in Protecting Rural America

    The CMS Administrator makes the case for expanded pharmacist test-and-treat authority — as more states enact it.